Recombinant Human JAG2 Protein，His

JAG2 (Jagged 2) is a ligand of the Notch signaling pathway, playing a critical role in cell-to-cell communication during development and in various physiological processes. As a key player in regulating cell fate, proliferation, and differentiation, JAG2 has garnered significant interest in the fields of developmental biology and cancer research. Abnormalities in the Notch signaling pathway, which JAG2 is part of, have been implicated in numerous pathologies including tumors, cardiovascular diseases, and neurodegenerative disorders. The study of JAG2 recombinant proteins is crucial for understanding its molecular mechanisms and functional roles. By producing JAG2 as a recombinant protein, researchers can investigate its binding affinity to Notch receptors, explore its structural properties, and evaluate its interactions with other signaling molecules. This research contributes to the broader understanding of Notch-mediated processes and may lead to the identification of novel therapeutic targets for diseases associated with dysregulated Notch signaling. Moreover, the ability to produce JAG2 in a controlled manner allows for high-throughput screening of potential inhibitors or activators, facilitating the development of targeted treatments. Overall, the investigation of JAG2 recombinant proteins is essential for delineating the complexities of the Notch signaling pathway and its implications in health and disease.